Gene ontology annotations for TUBB1 |
|
Experiment description of studies that identified TUBB1 in exosomes |
1 |
Experiment ID |
489 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 6 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
2 |
Experiment ID |
490 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 7 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
3 |
Experiment ID |
491 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
4 |
Experiment ID |
492 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 9 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
5 |
Experiment ID |
494 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD151|CD63|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Osteoarthritic cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
6 |
Experiment ID |
496 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Healthy cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
7 |
Experiment ID |
497 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
8 |
Experiment ID |
498 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
9 |
Experiment ID |
207 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DKO-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
10 |
Experiment ID |
208 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
Dks-8 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
11 |
Experiment ID |
209 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DLD-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
12 |
Experiment ID |
234 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-C3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
13 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
14 |
Experiment ID |
211 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
cytochrome c|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
IGROV1 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
15 |
Experiment ID |
212 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
Cytochrome C|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
OVCAR-3 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
16 |
Experiment ID |
231 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD63|CD9
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
17 |
Experiment ID |
232 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
18 |
Experiment ID |
233 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
19 |
Experiment ID |
275 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel sensitive |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.12-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
20 |
Experiment ID |
274 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel resistant |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
21 |
Experiment ID |
193 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD63|CD9
|
Enriched markers |
✔
PHB
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
21595033
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
Journal name |
Proteomics
|
Publication year |
2011 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
22 |
Experiment ID |
194 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
21595033
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
Journal name |
Proteomics
|
Publication year |
2011 |
Sample |
Urine |
Sample name |
Urine - Patients of basement membrane nephropathy |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
23 |
Experiment ID |
195 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
21595033
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
Journal name |
Proteomics
|
Publication year |
2011 |
Sample |
Urine |
Sample name |
Urine - Patients of early IgA nephropathy |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for TUBB1 |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
RNF149 |
284996 |
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
KLK15 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
3 |
CCT3 |
7203 |
Affinity Capture-MS |
|
Homo sapiens |
|
4 |
FBXO25 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
WNT7A |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
6 |
CELA1 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
7 |
NOP56 |
10528 |
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
CRHBP |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
CBWD2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
10 |
EBF2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
11 |
CCT6B |
10693 |
Affinity Capture-MS |
|
Homo sapiens |
|
12 |
CAND1 |
55832 |
Affinity Capture-MS |
|
Homo sapiens |
|
13 |
AAR2 |
25980 |
Affinity Capture-MS |
|
Homo sapiens |
|
14 |
MUC20 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
15 |
CCL18 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
16 |
GABRG2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
17 |
TM2D3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
18 |
BTLA |
|
Affinity Capture-MS |
|
Homo sapiens |
|
19 |
ANKMY2 |
57037 |
Affinity Capture-MS |
|
Homo sapiens |
|
20 |
WFIKKN1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
21 |
COPS6 |
10980 |
Affinity Capture-MS |
|
Homo sapiens |
|
22 |
COPS5 |
10987 |
Affinity Capture-MS |
|
Homo sapiens |
|
23 |
GLMP |
112770 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
24 |
FBLN2 |
2199 |
Affinity Capture-MS |
|
Homo sapiens |
|
25 |
FBL |
2091 |
Affinity Capture-MS |
|
Homo sapiens |
|
26 |
PPM1M |
|
Affinity Capture-MS |
|
Homo sapiens |
|
27 |
KLHL33 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
28 |
PSG8 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
29 |
ASTL |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
30 |
PLA2G10 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
PXK |
54899 |
Affinity Capture-MS |
|
Homo sapiens |
|
32 |
TCP11L1 |
55346 |
Affinity Capture-MS |
|
Homo sapiens |
|
33 |
IL17RA |
23765 |
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
CUL1 |
8454 |
Affinity Capture-MS |
|
Homo sapiens |
|
35 |
TFCP2 |
7024 |
Affinity Capture-MS |
|
Homo sapiens |
|
36 |
NPAS1 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
37 |
RAB1B |
81876 |
Affinity Capture-MS |
|
Homo sapiens |
|
38 |
CHMP4C |
92421 |
Affinity Capture-MS |
|
Homo sapiens |
|
39 |
EFNA2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
40 |
TCP1 |
6950 |
Affinity Capture-MS |
|
Homo sapiens |
|
41 |
DNLZ |
|
Affinity Capture-MS |
|
Homo sapiens |
|
42 |
CUL4B |
8450 |
Affinity Capture-MS |
|
Homo sapiens |
|
43 |
PARK2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
44 |
ZMYM2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
45 |
ALPI |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
46 |
TUBB2B |
347733 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
47 |
TUBA1B |
10376 |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
48 |
YAP1 |
10413 |
Affinity Capture-MS |
|
Homo sapiens |
|
49 |
SERPINC1 |
462 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
50 |
NEK4 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
51 |
ALDH3B1 |
221 |
Affinity Capture-MS |
|
Homo sapiens |
|
52 |
TACSTD2 |
4070 |
Affinity Capture-MS |
|
Homo sapiens |
|
53 |
NME3 |
4832 |
Affinity Capture-MS |
|
Homo sapiens |
|
54 |
CUL2 |
8453 |
Affinity Capture-MS |
|
Homo sapiens |
|
55 |
PRKAB1 |
5564 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
56 |
LIPG |
9388 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
57 |
ADAMTS17 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
58 |
USH1C |
|
Affinity Capture-MS |
|
Homo sapiens |
|
59 |
CLEC5A |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
60 |
MIER1 |
|
Co-fractionation |
|
Homo sapiens |
|
61 |
OTC |
5009 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
62 |
TUBB |
203068 |
Affinity Capture-MS |
|
Homo sapiens |
|
63 |
ADAMTS4 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
64 |
HADHB |
3032 |
Co-fractionation |
|
Homo sapiens |
|
65 |
PRG2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
66 |
PRSS50 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
67 |
CUL3 |
8452 |
Affinity Capture-MS |
|
Homo sapiens |
|
68 |
OLFM2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
69 |
TUBB4B |
10383 |
Affinity Capture-MS |
|
Homo sapiens |
|
70 |
MFSD11 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
71 |
RPGR |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
72 |
DNAI2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
73 |
IL12RB1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
74 |
ACAT1 |
38 |
Co-fractionation |
|
Homo sapiens |
|
75 |
ATP1B1 |
481 |
Affinity Capture-MS |
|
Homo sapiens |
|
76 |
ACAD9 |
28976 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
77 |
ENPP7 |
339221 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
78 |
DTWD2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
79 |
NPHP4 |
261734 |
Affinity Capture-MS |
|
Homo sapiens |
|
80 |
CCKBR |
|
Affinity Capture-MS |
|
Homo sapiens |
|
81 |
MYSM1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
82 |
MAGT1 |
84061 |
Affinity Capture-MS |
|
Homo sapiens |
|
83 |
TUBB2A |
7280 |
Affinity Capture-MS |
|
Homo sapiens |
|
84 |
SFRP4 |
6424 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
85 |
SNCA |
6622 |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
86 |
NAAA |
|
Affinity Capture-MS |
|
Homo sapiens |
|
87 |
SIRT6 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
88 |
PARP1 |
142 |
Affinity Capture-MS |
|
Homo sapiens |
|
89 |
PSG1 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
90 |
CTDSP1 |
58190 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
91 |
WDR77 |
79084 |
Affinity Capture-MS |
|
Homo sapiens |
|
92 |
TOR1AIP2 |
163590 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
93 |
TCTN1 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
94 |
DOCK5 |
80005 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
95 |
TUBG1 |
7283 |
Affinity Capture-MS |
|
Homo sapiens |
|
96 |
TSPYL6 |
|
| | | |